
    
      After being informed about the study and potential risks, all patients giving written
      informed consent wear a continuous glucose monitoring device ("iPro2" professional continuous
      glucose monitoring, MedtronicⓇ, California, USA) and smart band ("Fitbit Inspire HR",
      FitbitⓇ, California, USA) for 1 week.

      During this period, all patients are tested oral glucose tolerance test and take a standard
      diet (calorie calculated) at morning.

      The patient's data from this study is compared to a predicted values by mathematical analysis
      model for diabetes prevention.
    
  